Delhi Health Minister Satyendar Jain mention that the total of 1000 black fungus cases reported in Delhi.
Ground Report | New Delhi: Delhi recorded around 1000 cases of black fungus until Wednesday, state health minister Satyendar Jain has said. The minister also informed that 89 people died due to the infections in the national capital and 92 patients have recovered.
He also pointed out that there is a shortage of medicines to treat black fungus. This comes in the backdrop of the central government announcing restrictions on the import of Amphotericin-B, an anti-fungal drug used for the treatment of mucormycosis,(Black Fungus).
As per the notice issued by the Directorate General a Foreign Trade (DGFT), the export of the injections has been put in a restricted category. This is mean that an exporter would need permission on the license from the authority of these outbound shipments. With the rise in the number of black fungus cases among patients who have recovered from coronavirus, several Indian states have witnessed an acute shortage of Amphotericin-B injection.
Due to this, India has been importing medicines from other countries. A shipment of drugs and injections reaches India on Sunday from US pharma major Gilead Science. The company has further announced to supply more vials to India.
What Delhi High Court said on Black Fungus?
Among rising infections across the country, the Delhi HC has said that it’s high time for (ICRM )to issue guidelines for the treatment of black fungus. The court further directed the Central government to form a policy for its distribution. The Delhi HC said about the shortage of drugs in the entire country including Delhi for the last two weeks now.
It is also said that the law of the drug has to arrange for those with chances of survival and also the younger generation, having promise of the future over older ones who have lived their lives. High Court said that the center should from the policy on the distribution of Liposomal Amphotericin -B to treat Black Fungus, spell out the priority of patients.